Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q3 2025 Earnings

5AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.26

-0.98

-0.7

-0.42

Details

Expected EPS

-0.65096816772

Actual EPS

-0.4232473

Surprise EPS

0.23

Surprise Percent

+34.98%

Description

Spyre Therapeutics (3920.F) has reported earnings of -0.4232473 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.